PMID- 15145081 OWN - NLM STAT- MEDLINE DCOM- 20040729 LR - 20131121 IS - 0306-4522 (Print) IS - 0306-4522 (Linking) VI - 126 IP - 1 DP - 2004 TI - Ethanol inhibits brain-derived neurotrophic factor-mediated intracellular signaling and activator protein-1 activation in cerebellar granule neurons. PG - 149-62 AB - Developmental exposure to ethanol causes profound damage to the cerebellum, ranging from aberration in neuronal differentiation to cell loss. As a major neurotrophic factor, brain-derived neurotrophic factor (BDNF) and its receptor TrkB are expressed in the developing, as well as adult, cerebellum. Many neurotrophic effects of BDNF are mediated by gene transcription. We hypothesized that ethanol interfered with BDNF signaling and disrupted BDNF-regulated transcriptional activity. Using a transgenic mouse model expressing an activator protein-1 (AP-1) luciferase reporter construct, we demonstrated that BDNF stimulated AP-1 transactivation in cultured cerebellar granule neurons. This observation was validated by the study using a human neuronal cell line expressing inducible TrkB (TB8 neuroblastoma cells). BDNF induced AP-1 transactivation, as well as increased the binding activity of AP-1 protein complex to a DNA sequence containing AP-1 sites in TB8 cells. BDNF-mediated AP-1 activation was mediated by PI3K/Akt and JNK pathways; BDNF activated Akt and JNKs, and blocking these pathways significantly inhibited BDNF-stimulated AP-1 transactivation. More importantly, ethanol inhibited BDNF-mediated activation of PI3K/Akt and JNKs, and blocked BDNF-stimulated AP-1 activation. Since ethanol did not affect either the expression or autophosphorylation of TrkB, it could be concluded that the site of ethanol action was downstream of TrkB. The present study establishes that this AP-1 reporter transgenic mouse model is valuable for assessing AP-1 activity in the CNS neurons. Our results provide an insight into molecular mechanism(s) of ethanol action. FAU - Li, Z AU - Li Z AD - Department of Microbiology, West Virginia University School of Medicine, Robert C. Byrd Health Sciences Center, Morgantown, WV 26506, USA. FAU - Ding, M AU - Ding M FAU - Thiele, C J AU - Thiele CJ FAU - Luo, J AU - Luo J LA - eng GR - AA12968/AA/NIAAA NIH HHS/United States GR - CA90385/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Central Nervous System Depressants) RN - 0 (Transcription Factor AP-1) RN - 3K9958V90M (Ethanol) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - EC 2.7.10.1 (Receptor, trkB) RN - EC 2.7.11.24 (JNK Mitogen-Activated Protein Kinases) RN - EC 2.7.11.24 (Mitogen-Activated Protein Kinases) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/*pharmacology MH - Cell Communication/drug effects MH - Cell Line, Tumor MH - Central Nervous System Depressants/*pharmacology MH - Cerebellum/*cytology MH - Drug Interactions MH - Ethanol/*pharmacology MH - Humans MH - JNK Mitogen-Activated Protein Kinases MH - Mice MH - Mice, Transgenic MH - Mitogen-Activated Protein Kinases/metabolism MH - Neuroblastoma MH - Neurons/cytology/*drug effects/metabolism MH - Phosphatidylinositol 3-Kinases/metabolism MH - Phosphorylation/drug effects MH - Receptor, trkB/metabolism MH - Transcription Factor AP-1/*metabolism EDAT- 2004/05/18 05:00 MHDA- 2004/07/30 05:00 CRDT- 2004/05/18 05:00 PHST- 2004/03/18 00:00 [accepted] PHST- 2004/05/18 05:00 [pubmed] PHST- 2004/07/30 05:00 [medline] PHST- 2004/05/18 05:00 [entrez] AID - S0306452204002234 [pii] AID - 10.1016/j.neuroscience.2004.03.028 [doi] PST - ppublish SO - Neuroscience. 2004;126(1):149-62. doi: 10.1016/j.neuroscience.2004.03.028.